Seroprevalence of hepatitis B virus and hepatitis C virus infection among pregnant women attending antenatal care at Guhala Primary Hospital, Northwestern Ethiopia

• Published in: BMC pregnancy and childbirth 2024-07, Vol.24 (1), p.512-7, Article 512
• Main Authors: Belete, Debaka, Fekadie, Engidayehu, Kassaw, Melkamu, Fenta, Melaku, Jegnie, Azanu, Mulu, Tigist, Adane, Gashaw, Abebe, Wondwossen, Amare, Azanaw
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Age; Antigens; Blood & organ donations; Data collection; Ethiopia; Ethiopia - epidemiology; Female; Guhala; Hepacivirus - immunology; Hepatitis B; Hepatitis B - blood; Hepatitis B - epidemiology; Hepatitis B - transmission; Hepatitis B Surface Antigens - blood; Hepatitis B virus; Hepatitis B virus - immunology; Hepatitis C; Hepatitis C - blood; Hepatitis C - epidemiology; Hepatitis C - transmission; Hepatitis C Antibodies - blood; Hepatitis C virus; Hospitals; Humans; Infections; Infectious Disease Transmission, Vertical - statistics & numerical data; Laboratories; Liver cancer; Liver cirrhosis; Medical personnel; Mothers; Population; Pregnancy; Pregnancy Complications, Infectious - blood; Pregnancy Complications, Infectious - epidemiology; Pregnancy Complications, Infectious - virology; Pregnant women; Prenatal Care; Prevalence; Public health; Retrospective Studies; Seroepidemiologic Studies; Serology; Womens health; Young Adult
• ISSN: 1471-2393; 1471-2393
• DOI: 10.1186/s12884-024-06714-6

Hepatitis B virus (HBV) and Hepatitis C Virus (HCV) infections are global issues that disproportionately affect developing countries. Pregnancy-related HBV and HCV infections are associated with a high risk of vertical transmission and complications for the mother as well as the newborn. Therefore, this study aims to determine the seroprevalence of hepatitis B virus and hepatitis C virus infection among pregnant women attending antenatal care at Guhala Primary Hospital, Northwestern Ethiopia. A hospital-based retrospective study was conducted from July to September 2022 on HBV and HCV registered books from September 1, 2017, to August 30, 2019, for a year. The presence of HBsAg and anti-HCV in serum was detected using the One Step Cassette Style HBsAg and anti-HCV antibody test kit. Data were analyzed using SPSS version 26 software. In this study, a total of 2252 participants for HBsAg and 538 participants for ant-HCV rapid tests of records in the laboratory logbook were included. The mean age of the study participants was 25.6years (± 5.8SD). The overall prevalence of HBsAg and anti-HCV was 6.0% (134/2252) and 2.4% (13/538), respectively. There were 0.4% (2/538) coinfection results between HBV and HCV among pregnant women. In this study, intermediate seroprevalence of HBV and HCV infection was detected among pregnant women attending antenatal care. The Hepatitis B virus was predominantly higher among pregnant women aged between 25 and 34 years. To manage and stop the potential vertical transmission of these viral agents during the early stages of pregnancy, routine prenatal testing for HBV and HCV infections should be taken into consideration.